@DZalkowitz @dhovekamp42 @Jon12508683 Your approach is intelligent.

The idea of using combos to get better efficacy from checkpoint inhibitors is terrific, in theory.  But it’s been challenging. My dad recently participated in a trial combining an experimental intratumoral TLR9 Agonist injection w/ $PFE ’s Bavencio